Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Regeneron Pharmaceuticals
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Baptist Health South Florida
Eastern Cooperative Oncology Group
Children's Oncology Group
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Emory University
Regeneron Pharmaceuticals
Washington University School of Medicine
Massachusetts General Hospital
M.D. Anderson Cancer Center
BeOne Medicines
Sanofi
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Sanofi
Sumitomo Pharma America, Inc.
University of Liverpool
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Oncotherapeutics
Universitätsklinikum Hamburg-Eppendorf
Children's Oncology Group
Columbia University
Ipsen
University of Nebraska
Oncotherapeutics
Oncotherapeutics
Oncotherapeutics
Children's Oncology Group
Huashan Hospital
OHSU Knight Cancer Institute
Herlev Hospital
US Oncology Research
Sun Yat-sen University
M.D. Anderson Cancer Center
Fundacion GenesisCare
Guangzhou Institute of Respiratory Disease
University of California, Davis
Mesoblast, Ltd.
Incyte Corporation
Sun Pharmaceutical Industries Limited